An average trading volume for Sana Biotechnology Inc. (SANA) has been steady over the recent period.

After finishing at $4.76 in the prior trading day, Sana Biotechnology Inc. (NASDAQ: SANA) closed at $4.66, down -2.10%. In other words, the price has decreased by -$0.1000 from its previous closing price. On the day, 595564 shares were traded. SANA stock price reached its highest trading level at $4.8300 during the session, while it also had its lowest trading level at $4.5600.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

Ratios:

Our goal is to gain a better understanding of SANA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.40 and its Current Ratio is at 4.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on March 01, 2021, initiated with a Overweight rating and assigned the stock a target price of $40.

On March 01, 2021, JP Morgan started tracking the stock assigning a Neutral rating and target price of $35.

On March 01, 2021, Goldman started tracking the stock assigning a Neutral rating and target price of $40.Goldman initiated its Neutral rating on March 01, 2021, with a $40 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 when Yang Patrick Y bought 28,000 shares for $7.30 per share. The transaction valued at 204,400 led to the insider holds 174,250 shares of the business.

MacDonald James J. sold 333 shares of SANA for $2,091 on Feb 18. The EVP & General Counsel now owns 429,417 shares after completing the transaction at $6.28 per share.

Stock Price History:

Over the past 52 weeks, SANA has reached a high of $21.72, while it has fallen to a 52-week low of $3.92. The 50-Day Moving Average of the stock is 5.7392, while the 200-Day Moving Average is calculated to be 6.5454.

Shares Statistics:

The stock has traded on average 1.13M shares per day over the past 3-months and 1.24M shares per day over the last 10 days, according to various share statistics. A total of 189.30M shares are outstanding, with a floating share count of 166.47M. Insiders hold about 3.30% of the company’s shares, while institutions hold 89.70% stake in the company. Shares short for SANA as of Oct 13, 2022 were 25.27M with a Short Ratio of 25.44M, compared to 25.91M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 13.29% and a Short% of Float of 28.00%.

Earnings Estimates

Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.53 for the current quarter, with a high estimate of -$0.53 and a low estimate of -$0.53, while EPS last year was -$0.46. The consensus estimate for the next quarter is -$0.74, with high estimates of -$0.57 and low estimates of -$0.92.

Analysts are recommending an EPS of between -$1.64 and -$2.3 for the fiscal current year, implying an average EPS of -$2.02. EPS for the following year is -$2.37, with 3 analysts recommending between -$2.15 and -$2.8.